LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV

This adverse event was reported 3372 times

These drugs are most commonly taken by patients reporting LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV:

# Drug Count
0 RANITIDINE 271
1 RANITIDINE HYDROCHLORIDE 111
2 APIXABAN 53
3 ALBUTEROL SULFATE 50
4 ADALIMUMAB 46
5 OSIMERTINIB 44
6 INTERFERON BETA-1A 43
7 ASPIRIN 42
8 METHOTREXATE SODIUM 42
9 PREDNISONE 42
See all common drugs associated with LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV

LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 1 0.0333
1 ECHOTHIOPHATE IODIDE FOR OPHTHALMIC SOLUTION 1 0.0068
2 USTEKINUMAB-STBA 2 0.0054
3 QUAZEPAM 1 0.0033
4 VON WILLEBRAND FACTOR (RECOMBINANT) 1 0.0032
5 GLYCERINE 1 0.0031
6 CLARIFYING DETOX (ACNE TREATMENT) MASK 1 0.0029
7 BELINOSTAT 1 0.0028
8 GARADACIMAB 2 0.0026
9 CAPMATINIB 6 0.0025
See all drugs enriched for association with LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV